WO2011049960A9 - Compositions et méthodes pour le traitement des troubles nasosinusiens - Google Patents
Compositions et méthodes pour le traitement des troubles nasosinusiens Download PDFInfo
- Publication number
- WO2011049960A9 WO2011049960A9 PCT/US2010/053217 US2010053217W WO2011049960A9 WO 2011049960 A9 WO2011049960 A9 WO 2011049960A9 US 2010053217 W US2010053217 W US 2010053217W WO 2011049960 A9 WO2011049960 A9 WO 2011049960A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sinonasal
- disorders
- compositions
- treatment
- methods
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25378209P | 2009-10-21 | 2009-10-21 | |
US61/253,782 | 2009-10-21 | ||
US25537909P | 2009-10-27 | 2009-10-27 | |
US61/255,379 | 2009-10-27 | ||
US25578309P | 2009-10-28 | 2009-10-28 | |
US25578009P | 2009-10-28 | 2009-10-28 | |
US61/255,780 | 2009-10-28 | ||
US61/255,783 | 2009-10-28 | ||
US29717010P | 2010-01-21 | 2010-01-21 | |
US29713810P | 2010-01-21 | 2010-01-21 | |
US61/297,170 | 2010-01-21 | ||
US61/297,138 | 2010-01-21 | ||
US36428710P | 2010-07-14 | 2010-07-14 | |
US61/364,287 | 2010-07-14 | ||
US36667710P | 2010-07-21 | 2010-07-21 | |
US61/366,677 | 2010-07-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011049960A2 WO2011049960A2 (fr) | 2011-04-28 |
WO2011049960A9 true WO2011049960A9 (fr) | 2011-08-18 |
Family
ID=43900967
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/053217 WO2011049960A2 (fr) | 2009-10-21 | 2010-10-19 | Compositions et méthodes pour le traitement des troubles nasosinusiens |
PCT/US2010/053616 WO2011050206A2 (fr) | 2009-10-21 | 2010-10-21 | Compositions et procédés pour le traitement de troubles sino-nasaux |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/053616 WO2011050206A2 (fr) | 2009-10-21 | 2010-10-21 | Compositions et procédés pour le traitement de troubles sino-nasaux |
Country Status (1)
Country | Link |
---|---|
WO (2) | WO2011049960A2 (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1962805T3 (pl) | 2005-12-08 | 2017-01-31 | Insmed Incorporated | Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych |
US8119156B2 (en) | 2006-10-24 | 2012-02-21 | Aradigm Corporation | Dual action, inhaled formulations providing both an immediate and sustained release profile |
AU2012211514B2 (en) * | 2006-10-24 | 2014-07-31 | Aradigm Corporation | Concentrated, inhalable ciprofloxacin formulation |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
WO2013009761A1 (fr) | 2011-07-13 | 2013-01-17 | The Foundry, Llc | Procédés et appareil pour administrer un agent thérapeutique à des cibles de la muqueuse nasopharyngée |
SG11201407676VA (en) * | 2012-05-21 | 2015-03-30 | Agency Science Tech & Res | A dry powder formulation |
CA2891487A1 (fr) | 2012-11-29 | 2014-06-05 | Insmed Incorporated | Formulations de vancomycine stabilisees |
EP2759290B1 (fr) | 2013-01-24 | 2019-11-06 | Merz Pharma GmbH & Co. KGaA | Composition liquide pulverisable pour application nasale avec un delai local retentissant augmente |
DE202013000748U1 (de) | 2013-01-24 | 2013-02-19 | Merz Pharma Gmbh & Co. Kgaa | Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit |
DE102013001151A1 (de) | 2013-01-24 | 2014-07-24 | Merz Pharma Gmbh & Co. Kgaa | Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit |
US20140371305A1 (en) * | 2013-06-14 | 2014-12-18 | Professional Compounding Centers Of America | Mupirocin Antibiotic Composition |
US20150164882A1 (en) | 2013-07-22 | 2015-06-18 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
US20160279055A1 (en) | 2013-07-22 | 2016-09-29 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof |
US9987227B2 (en) | 2013-10-22 | 2018-06-05 | Aradigm Corporation | Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile |
PL3142643T3 (pl) | 2014-05-15 | 2019-12-31 | Insmed Incorporated | Sposoby leczenia zakażeń płuc prątkami niegruźliczymi |
EP3164115A4 (fr) | 2014-07-03 | 2017-05-17 | Otonomy, Inc. | Stérilisation d'une composition de ciprofloxacine |
CN104341405B (zh) * | 2014-09-25 | 2016-09-14 | 武汉大学 | 一种具有抑制Aβ聚集活性的化合物的制备方法与用途 |
WO2017105356A1 (fr) | 2015-12-18 | 2017-06-22 | Ak-Kim Kimya Sanayi Ve Ticaret Anonim Sirketi | Module de membrane à fibres creuses |
CN105902543B (zh) * | 2016-04-28 | 2019-02-12 | 华北制药股份有限公司 | 一种高纯度美洛西林钠制剂及其制备方法 |
US20180071281A1 (en) * | 2016-08-19 | 2018-03-15 | Gerbe Labs Inc. | Treating chronic rhinosinusitis |
WO2019191627A1 (fr) | 2018-03-30 | 2019-10-03 | Insmed Incorporated | Procédés pour la fabrication continue de produits médicamenteux liposomaux |
CN110141559A (zh) * | 2019-06-18 | 2019-08-20 | 浦易(上海)生物技术有限公司 | 一种用于鼻粘膜的含药缓释微粒及其应用 |
US20210315883A1 (en) * | 2020-04-08 | 2021-10-14 | Nostrum Pharmaceuticals, Llc | Compositions and methods for the prophylaxis and/or treatment of viral infections or conditions associated therewith |
US20220135653A1 (en) * | 2020-11-05 | 2022-05-05 | Bravado Pharmaceuticals, LLC | Intranasal Antiviral Therapy for Mucosal Protection Against Virus Infections |
CN113456580B (zh) * | 2021-07-21 | 2024-03-22 | 沈阳化工大学 | 一种白藜芦醇原位凝胶制备及其表征方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1164227B (it) * | 1983-05-13 | 1987-04-08 | Angeli Inst Spa | Composizione farmaceutica atta alla somministrazione nasale di sali quaternari d'ammonio ed attivita' anticolinergica |
GB9310412D0 (en) * | 1993-05-20 | 1993-07-07 | Danbiosyst Uk | Nasal nicotine system |
-
2010
- 2010-10-19 WO PCT/US2010/053217 patent/WO2011049960A2/fr active Application Filing
- 2010-10-21 WO PCT/US2010/053616 patent/WO2011050206A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011050206A3 (fr) | 2011-09-22 |
WO2011050206A2 (fr) | 2011-04-28 |
WO2011049960A2 (fr) | 2011-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011049960A9 (fr) | Compositions et méthodes pour le traitement des troubles nasosinusiens | |
HK1174064A1 (zh) | 用於細胞增殖相關的疾病的方法和組合物 | |
EP2406389A4 (fr) | Procédés et compositions pour des troubles liés à la prolifération cellulaire | |
EP2552433A4 (fr) | Compositions et procédés pour le traitement de troubles somatosensoriels | |
EP2293800A4 (fr) | Compositions et procédés pour le traitement de troubles de l'oreille | |
EP2361089A4 (fr) | Compositions et procédés pour le traitement d une fonction altérée de l' -synucléine | |
HK1166305A1 (zh) | 用於治療炎症的組合物及方法 | |
HK1159498A1 (en) | Methods and compositions for the treatment of cancer | |
SI2300614T1 (sl) | Metode in sestavki za zdravljenje mitohondrijskih motenj | |
WO2011071995A9 (fr) | Composés et procédés de traitement de troubles oculaires | |
EP2429584A4 (fr) | Procédés et compositions de traitement | |
EP2340027A4 (fr) | Procédés et compositions destinés au traitement du cancer | |
WO2012021287A9 (fr) | Procédés pour le traitement et la prévention de maladies métaboliques | |
IL214349A0 (en) | Compositions and methods for the treatment of cancer | |
HK1160598A1 (zh) | 治療腎功能紊亂的組合物和方法 | |
WO2011112588A9 (fr) | Compositions et méthodes pour le traitement de troubles inflammatoires | |
EP2437738A4 (fr) | Procédés et compositions pour le traitement du cancer | |
EP2675275A4 (fr) | Compositions et méthodes utilisables en vue du traitement de l'obésité et des troubles associés | |
EP2491019A4 (fr) | Méthodes et compositions pour les troubles de panique | |
EP2424885A4 (fr) | Compositions et procédés pour le traitement de troubles mettant en jeu une apoptose de cellules épithéliales | |
HU0900231D0 (en) | Compositions for the treatment of allergic disorders | |
EP2411031A4 (fr) | Méthodes et compositions pour le traitement du cancer | |
EP2547368A4 (fr) | Méthodes et compositions pour le traitement du cancer | |
EP2370087A4 (fr) | Méthodes et compositions pour le traitement de troubles de rétention de fluide | |
WO2010111374A9 (fr) | Compositions et procédés pour soulager des affections cutanées |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10825526 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10825526 Country of ref document: EP Kind code of ref document: A2 |